Age trends in asymptomatic and symptomatic Leishmania donovani infection in the Indian subcontinent: A review and analysis of data from diagnostic and epidemiological studies
Age patterns in asymptomatic and symptomatic infection with Leishmania donovani, the causative agent of visceral leishmaniasis (VL) in the Indian subcontinent (ISC), are currently poorly understood. Age-stratified serology and infection incidence have been used to assess transmission levels of other...
Gespeichert in:
Veröffentlicht in: | PLoS neglected tropical diseases 2018-12, Vol.12 (12), p.e0006803-e0006803 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e0006803 |
---|---|
container_issue | 12 |
container_start_page | e0006803 |
container_title | PLoS neglected tropical diseases |
container_volume | 12 |
creator | Chapman, Lloyd A C Morgan, Alex L K Adams, Emily R Bern, Caryn Medley, Graham F Hollingsworth, T Déirdre |
description | Age patterns in asymptomatic and symptomatic infection with Leishmania donovani, the causative agent of visceral leishmaniasis (VL) in the Indian subcontinent (ISC), are currently poorly understood. Age-stratified serology and infection incidence have been used to assess transmission levels of other diseases, which suggests that they may also be of use for monitoring and targeting control programmes to achieve elimination of VL and should be included in VL transmission dynamic models. We therefore analysed available age-stratified data on both disease incidence and prevalence of immune markers with the aim of collating the currently available data, estimating rates of infection, and informing modelling and future data collection.
A systematic literature search yielded 13 infection prevalence and 7 VL incidence studies meeting the inclusion criteria. Statistical tests were performed to identify trends by age, and according to diagnostic cut-off. Simple reversible catalytic models with age-independent and age-dependent infection rates were fitted to the prevalence data to estimate infection and reversion rates, and to test different hypotheses about the origin of variation in these rates. Most of the studies showed an increase in infection prevalence with age: from ≲10% seroprevalence (10% seroprevalence (>20% LST-positivity) for 30-40-year-olds, but overall prevalence varied considerably between studies. VL incidence was lower amongst 0-5-year-olds than older age groups in most studies; most showing a peak in incidence between ages 5 and 20. The age-independent catalytic model provided the best overall fit to the infection prevalence data, but the estimated rates for the less parsimonious age-dependent model were much closer to estimates from longitudinal studies, suggesting that infection rates may increase with age.
Age patterns in asymptomatic infection prevalence and VL incidence in the ISC vary considerably with geographical location and time period. The increase in infection prevalence with age and peaked age-VL-incidence distribution may be due to lower exposure to infectious sandfly bites in young children, but also suggest that acquired immunity to the parasite increases with age. However, poor standardisation of serological tests makes it difficult to compare data from different studies and draw firm conclusions about drivers of variation in observed age patterns. |
doi_str_mv | 10.1371/journal.pntd.0006803 |
format | Article |
fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2262859095</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A568167762</galeid><doaj_id>oai_doaj_org_article_9340fb31b3074c87bdb7c50c2fa53666</doaj_id><sourcerecordid>A568167762</sourcerecordid><originalsourceid>FETCH-LOGICAL-c624t-956ba69f6bcff1ffb5ea80b8270f32cba008ccf80ba67386c4376445f0ac09063</originalsourceid><addsrcrecordid>eNptUtuK1DAYLqK46-obiAYE8WbGpGnS1gthWDwsDHij1-FvmnQytMmYpCPzUj6j6U5nmZElF03_fIf_lGWvCV4SWpKPWzd6C_1yZ2O7xBjzCtMn2TWpKVvkJWVPz-5X2YsQthizmlXkeXZFMcsJy_l19nfVKRS9sm1AxiIIh2EX3QDRSAS2Ref_a2XCZgBrALXOun26JY5WMhpnJ3bcKHRnWwMWhbGRzkZjlY2f0Ap5tTfqz70kpKwPwQTkNGohAtLeDSixOuvCyVftTKsG43rXGQk9CnFsjQovs2ca-qBezd-b7NfXLz9vvy_WP77d3a7WC8nzIi5qxhvgteaN1Jpo3TAFFW6qvMSa5rIBjCspdQoBL2nFZUFLXhRMY5C4xpzeZG-PurveBTG3Oog853nFalyzhLg7IloHW7HzZgB_EA6MuA843wnwqZpeiZoWWDeUNBSXhazKpm1KybDMNTDK-eT2eXYbm0G1MvXMQ38hevlizUZ0bi9SNpTlRRL4MAt493tUIYrBBKn6HqxyY8qbcEbSzKvJ691_0Merm1EdpALSkF3ylZOoWDFeEV6WPE-o5SOodKbRpfErbVL8gvD-jLBR0MdNcP04LVC4BBZHoPQuBK_0QzMIFtP6n7IW0_qLef0T7c15Ix9Ip32n_wDYNgVm</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2262859095</pqid></control><display><type>article</type><title>Age trends in asymptomatic and symptomatic Leishmania donovani infection in the Indian subcontinent: A review and analysis of data from diagnostic and epidemiological studies</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><source>Public Library of Science (PLoS)</source><creator>Chapman, Lloyd A C ; Morgan, Alex L K ; Adams, Emily R ; Bern, Caryn ; Medley, Graham F ; Hollingsworth, T Déirdre</creator><contributor>Milon, Genevieve</contributor><creatorcontrib>Chapman, Lloyd A C ; Morgan, Alex L K ; Adams, Emily R ; Bern, Caryn ; Medley, Graham F ; Hollingsworth, T Déirdre ; Milon, Genevieve</creatorcontrib><description>Age patterns in asymptomatic and symptomatic infection with Leishmania donovani, the causative agent of visceral leishmaniasis (VL) in the Indian subcontinent (ISC), are currently poorly understood. Age-stratified serology and infection incidence have been used to assess transmission levels of other diseases, which suggests that they may also be of use for monitoring and targeting control programmes to achieve elimination of VL and should be included in VL transmission dynamic models. We therefore analysed available age-stratified data on both disease incidence and prevalence of immune markers with the aim of collating the currently available data, estimating rates of infection, and informing modelling and future data collection.
A systematic literature search yielded 13 infection prevalence and 7 VL incidence studies meeting the inclusion criteria. Statistical tests were performed to identify trends by age, and according to diagnostic cut-off. Simple reversible catalytic models with age-independent and age-dependent infection rates were fitted to the prevalence data to estimate infection and reversion rates, and to test different hypotheses about the origin of variation in these rates. Most of the studies showed an increase in infection prevalence with age: from ≲10% seroprevalence (<20% Leishmanin skin test (LST) positivity) for 0-10-year-olds to >10% seroprevalence (>20% LST-positivity) for 30-40-year-olds, but overall prevalence varied considerably between studies. VL incidence was lower amongst 0-5-year-olds than older age groups in most studies; most showing a peak in incidence between ages 5 and 20. The age-independent catalytic model provided the best overall fit to the infection prevalence data, but the estimated rates for the less parsimonious age-dependent model were much closer to estimates from longitudinal studies, suggesting that infection rates may increase with age.
Age patterns in asymptomatic infection prevalence and VL incidence in the ISC vary considerably with geographical location and time period. The increase in infection prevalence with age and peaked age-VL-incidence distribution may be due to lower exposure to infectious sandfly bites in young children, but also suggest that acquired immunity to the parasite increases with age. However, poor standardisation of serological tests makes it difficult to compare data from different studies and draw firm conclusions about drivers of variation in observed age patterns.</description><identifier>ISSN: 1935-2735</identifier><identifier>ISSN: 1935-2727</identifier><identifier>EISSN: 1935-2735</identifier><identifier>DOI: 10.1371/journal.pntd.0006803</identifier><identifier>PMID: 30521526</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Age ; Age composition ; Age Distribution ; Age groups ; Agglutination tests ; Asia, Western - epidemiology ; Asymptomatic infection ; Biology and Life Sciences ; Bites ; Catalysis ; Children ; Collating ; Correlation analysis ; Data ; Data analysis ; Data collection ; Demographic aspects ; Diagnostic systems ; Disease age factors ; Disease transmission ; Distribution ; Dynamic models ; Epidemiology ; Female ; Geographical distribution ; Geographical locations ; Health surveillance ; Humans ; Immunity ; Incidence ; Infections ; Infectious diseases ; Insect bites ; Leishmania donovani ; Leishmania donovani - immunology ; Leishmania donovani - isolation & purification ; Leishmaniasis, Visceral - diagnosis ; Leishmaniasis, Visceral - epidemiology ; Leishmaniasis, Visceral - parasitology ; Leishmaniasis, Visceral - transmission ; Leishmanin ; Life sciences ; Longitudinal Studies ; Male ; Medical research ; Medicine ; Medicine and Health Sciences ; Models, Statistical ; Parasites ; Parasitic diseases ; People and Places ; Prevalence ; Programmes ; Public health ; Research and Analysis Methods ; Reversion ; Seroepidemiologic Studies ; Serological tests ; Serology ; Skin ; Skin tests ; Statistical analysis ; Statistical tests ; Studies ; Transmission ; Trends ; Tropical diseases ; Vector-borne diseases ; Visceral leishmaniasis</subject><ispartof>PLoS neglected tropical diseases, 2018-12, Vol.12 (12), p.e0006803-e0006803</ispartof><rights>COPYRIGHT 2018 Public Library of Science</rights><rights>2018 Chapman et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2018 Chapman et al 2018 Chapman et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c624t-956ba69f6bcff1ffb5ea80b8270f32cba008ccf80ba67386c4376445f0ac09063</citedby><cites>FETCH-LOGICAL-c624t-956ba69f6bcff1ffb5ea80b8270f32cba008ccf80ba67386c4376445f0ac09063</cites><orcidid>0000-0001-7727-7102 ; 0000-0002-5740-9734</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283524/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283524/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,23845,27901,27902,53766,53768,79343,79344</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30521526$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Milon, Genevieve</contributor><creatorcontrib>Chapman, Lloyd A C</creatorcontrib><creatorcontrib>Morgan, Alex L K</creatorcontrib><creatorcontrib>Adams, Emily R</creatorcontrib><creatorcontrib>Bern, Caryn</creatorcontrib><creatorcontrib>Medley, Graham F</creatorcontrib><creatorcontrib>Hollingsworth, T Déirdre</creatorcontrib><title>Age trends in asymptomatic and symptomatic Leishmania donovani infection in the Indian subcontinent: A review and analysis of data from diagnostic and epidemiological studies</title><title>PLoS neglected tropical diseases</title><addtitle>PLoS Negl Trop Dis</addtitle><description>Age patterns in asymptomatic and symptomatic infection with Leishmania donovani, the causative agent of visceral leishmaniasis (VL) in the Indian subcontinent (ISC), are currently poorly understood. Age-stratified serology and infection incidence have been used to assess transmission levels of other diseases, which suggests that they may also be of use for monitoring and targeting control programmes to achieve elimination of VL and should be included in VL transmission dynamic models. We therefore analysed available age-stratified data on both disease incidence and prevalence of immune markers with the aim of collating the currently available data, estimating rates of infection, and informing modelling and future data collection.
A systematic literature search yielded 13 infection prevalence and 7 VL incidence studies meeting the inclusion criteria. Statistical tests were performed to identify trends by age, and according to diagnostic cut-off. Simple reversible catalytic models with age-independent and age-dependent infection rates were fitted to the prevalence data to estimate infection and reversion rates, and to test different hypotheses about the origin of variation in these rates. Most of the studies showed an increase in infection prevalence with age: from ≲10% seroprevalence (<20% Leishmanin skin test (LST) positivity) for 0-10-year-olds to >10% seroprevalence (>20% LST-positivity) for 30-40-year-olds, but overall prevalence varied considerably between studies. VL incidence was lower amongst 0-5-year-olds than older age groups in most studies; most showing a peak in incidence between ages 5 and 20. The age-independent catalytic model provided the best overall fit to the infection prevalence data, but the estimated rates for the less parsimonious age-dependent model were much closer to estimates from longitudinal studies, suggesting that infection rates may increase with age.
Age patterns in asymptomatic infection prevalence and VL incidence in the ISC vary considerably with geographical location and time period. The increase in infection prevalence with age and peaked age-VL-incidence distribution may be due to lower exposure to infectious sandfly bites in young children, but also suggest that acquired immunity to the parasite increases with age. However, poor standardisation of serological tests makes it difficult to compare data from different studies and draw firm conclusions about drivers of variation in observed age patterns.</description><subject>Age</subject><subject>Age composition</subject><subject>Age Distribution</subject><subject>Age groups</subject><subject>Agglutination tests</subject><subject>Asia, Western - epidemiology</subject><subject>Asymptomatic infection</subject><subject>Biology and Life Sciences</subject><subject>Bites</subject><subject>Catalysis</subject><subject>Children</subject><subject>Collating</subject><subject>Correlation analysis</subject><subject>Data</subject><subject>Data analysis</subject><subject>Data collection</subject><subject>Demographic aspects</subject><subject>Diagnostic systems</subject><subject>Disease age factors</subject><subject>Disease transmission</subject><subject>Distribution</subject><subject>Dynamic models</subject><subject>Epidemiology</subject><subject>Female</subject><subject>Geographical distribution</subject><subject>Geographical locations</subject><subject>Health surveillance</subject><subject>Humans</subject><subject>Immunity</subject><subject>Incidence</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Insect bites</subject><subject>Leishmania donovani</subject><subject>Leishmania donovani - immunology</subject><subject>Leishmania donovani - isolation & purification</subject><subject>Leishmaniasis, Visceral - diagnosis</subject><subject>Leishmaniasis, Visceral - epidemiology</subject><subject>Leishmaniasis, Visceral - parasitology</subject><subject>Leishmaniasis, Visceral - transmission</subject><subject>Leishmanin</subject><subject>Life sciences</subject><subject>Longitudinal Studies</subject><subject>Male</subject><subject>Medical research</subject><subject>Medicine</subject><subject>Medicine and Health Sciences</subject><subject>Models, Statistical</subject><subject>Parasites</subject><subject>Parasitic diseases</subject><subject>People and Places</subject><subject>Prevalence</subject><subject>Programmes</subject><subject>Public health</subject><subject>Research and Analysis Methods</subject><subject>Reversion</subject><subject>Seroepidemiologic Studies</subject><subject>Serological tests</subject><subject>Serology</subject><subject>Skin</subject><subject>Skin tests</subject><subject>Statistical analysis</subject><subject>Statistical tests</subject><subject>Studies</subject><subject>Transmission</subject><subject>Trends</subject><subject>Tropical diseases</subject><subject>Vector-borne diseases</subject><subject>Visceral leishmaniasis</subject><issn>1935-2735</issn><issn>1935-2727</issn><issn>1935-2735</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNptUtuK1DAYLqK46-obiAYE8WbGpGnS1gthWDwsDHij1-FvmnQytMmYpCPzUj6j6U5nmZElF03_fIf_lGWvCV4SWpKPWzd6C_1yZ2O7xBjzCtMn2TWpKVvkJWVPz-5X2YsQthizmlXkeXZFMcsJy_l19nfVKRS9sm1AxiIIh2EX3QDRSAS2Ref_a2XCZgBrALXOun26JY5WMhpnJ3bcKHRnWwMWhbGRzkZjlY2f0Ap5tTfqz70kpKwPwQTkNGohAtLeDSixOuvCyVftTKsG43rXGQk9CnFsjQovs2ca-qBezd-b7NfXLz9vvy_WP77d3a7WC8nzIi5qxhvgteaN1Jpo3TAFFW6qvMSa5rIBjCspdQoBL2nFZUFLXhRMY5C4xpzeZG-PurveBTG3Oog853nFalyzhLg7IloHW7HzZgB_EA6MuA843wnwqZpeiZoWWDeUNBSXhazKpm1KybDMNTDK-eT2eXYbm0G1MvXMQ38hevlizUZ0bi9SNpTlRRL4MAt493tUIYrBBKn6HqxyY8qbcEbSzKvJ691_0Merm1EdpALSkF3ylZOoWDFeEV6WPE-o5SOodKbRpfErbVL8gvD-jLBR0MdNcP04LVC4BBZHoPQuBK_0QzMIFtP6n7IW0_qLef0T7c15Ix9Ip32n_wDYNgVm</recordid><startdate>20181201</startdate><enddate>20181201</enddate><creator>Chapman, Lloyd A C</creator><creator>Morgan, Alex L K</creator><creator>Adams, Emily R</creator><creator>Bern, Caryn</creator><creator>Medley, Graham F</creator><creator>Hollingsworth, T Déirdre</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7SS</scope><scope>7T2</scope><scope>7T7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>F1W</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>H95</scope><scope>H97</scope><scope>K9.</scope><scope>L.G</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-7727-7102</orcidid><orcidid>https://orcid.org/0000-0002-5740-9734</orcidid></search><sort><creationdate>20181201</creationdate><title>Age trends in asymptomatic and symptomatic Leishmania donovani infection in the Indian subcontinent: A review and analysis of data from diagnostic and epidemiological studies</title><author>Chapman, Lloyd A C ; Morgan, Alex L K ; Adams, Emily R ; Bern, Caryn ; Medley, Graham F ; Hollingsworth, T Déirdre</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c624t-956ba69f6bcff1ffb5ea80b8270f32cba008ccf80ba67386c4376445f0ac09063</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Age</topic><topic>Age composition</topic><topic>Age Distribution</topic><topic>Age groups</topic><topic>Agglutination tests</topic><topic>Asia, Western - epidemiology</topic><topic>Asymptomatic infection</topic><topic>Biology and Life Sciences</topic><topic>Bites</topic><topic>Catalysis</topic><topic>Children</topic><topic>Collating</topic><topic>Correlation analysis</topic><topic>Data</topic><topic>Data analysis</topic><topic>Data collection</topic><topic>Demographic aspects</topic><topic>Diagnostic systems</topic><topic>Disease age factors</topic><topic>Disease transmission</topic><topic>Distribution</topic><topic>Dynamic models</topic><topic>Epidemiology</topic><topic>Female</topic><topic>Geographical distribution</topic><topic>Geographical locations</topic><topic>Health surveillance</topic><topic>Humans</topic><topic>Immunity</topic><topic>Incidence</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Insect bites</topic><topic>Leishmania donovani</topic><topic>Leishmania donovani - immunology</topic><topic>Leishmania donovani - isolation & purification</topic><topic>Leishmaniasis, Visceral - diagnosis</topic><topic>Leishmaniasis, Visceral - epidemiology</topic><topic>Leishmaniasis, Visceral - parasitology</topic><topic>Leishmaniasis, Visceral - transmission</topic><topic>Leishmanin</topic><topic>Life sciences</topic><topic>Longitudinal Studies</topic><topic>Male</topic><topic>Medical research</topic><topic>Medicine</topic><topic>Medicine and Health Sciences</topic><topic>Models, Statistical</topic><topic>Parasites</topic><topic>Parasitic diseases</topic><topic>People and Places</topic><topic>Prevalence</topic><topic>Programmes</topic><topic>Public health</topic><topic>Research and Analysis Methods</topic><topic>Reversion</topic><topic>Seroepidemiologic Studies</topic><topic>Serological tests</topic><topic>Serology</topic><topic>Skin</topic><topic>Skin tests</topic><topic>Statistical analysis</topic><topic>Statistical tests</topic><topic>Studies</topic><topic>Transmission</topic><topic>Trends</topic><topic>Tropical diseases</topic><topic>Vector-borne diseases</topic><topic>Visceral leishmaniasis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chapman, Lloyd A C</creatorcontrib><creatorcontrib>Morgan, Alex L K</creatorcontrib><creatorcontrib>Adams, Emily R</creatorcontrib><creatorcontrib>Bern, Caryn</creatorcontrib><creatorcontrib>Medley, Graham F</creatorcontrib><creatorcontrib>Hollingsworth, T Déirdre</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ASFA: Aquatic Sciences and Fisheries Abstracts</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) Professional</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PLoS neglected tropical diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chapman, Lloyd A C</au><au>Morgan, Alex L K</au><au>Adams, Emily R</au><au>Bern, Caryn</au><au>Medley, Graham F</au><au>Hollingsworth, T Déirdre</au><au>Milon, Genevieve</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Age trends in asymptomatic and symptomatic Leishmania donovani infection in the Indian subcontinent: A review and analysis of data from diagnostic and epidemiological studies</atitle><jtitle>PLoS neglected tropical diseases</jtitle><addtitle>PLoS Negl Trop Dis</addtitle><date>2018-12-01</date><risdate>2018</risdate><volume>12</volume><issue>12</issue><spage>e0006803</spage><epage>e0006803</epage><pages>e0006803-e0006803</pages><issn>1935-2735</issn><issn>1935-2727</issn><eissn>1935-2735</eissn><abstract>Age patterns in asymptomatic and symptomatic infection with Leishmania donovani, the causative agent of visceral leishmaniasis (VL) in the Indian subcontinent (ISC), are currently poorly understood. Age-stratified serology and infection incidence have been used to assess transmission levels of other diseases, which suggests that they may also be of use for monitoring and targeting control programmes to achieve elimination of VL and should be included in VL transmission dynamic models. We therefore analysed available age-stratified data on both disease incidence and prevalence of immune markers with the aim of collating the currently available data, estimating rates of infection, and informing modelling and future data collection.
A systematic literature search yielded 13 infection prevalence and 7 VL incidence studies meeting the inclusion criteria. Statistical tests were performed to identify trends by age, and according to diagnostic cut-off. Simple reversible catalytic models with age-independent and age-dependent infection rates were fitted to the prevalence data to estimate infection and reversion rates, and to test different hypotheses about the origin of variation in these rates. Most of the studies showed an increase in infection prevalence with age: from ≲10% seroprevalence (<20% Leishmanin skin test (LST) positivity) for 0-10-year-olds to >10% seroprevalence (>20% LST-positivity) for 30-40-year-olds, but overall prevalence varied considerably between studies. VL incidence was lower amongst 0-5-year-olds than older age groups in most studies; most showing a peak in incidence between ages 5 and 20. The age-independent catalytic model provided the best overall fit to the infection prevalence data, but the estimated rates for the less parsimonious age-dependent model were much closer to estimates from longitudinal studies, suggesting that infection rates may increase with age.
Age patterns in asymptomatic infection prevalence and VL incidence in the ISC vary considerably with geographical location and time period. The increase in infection prevalence with age and peaked age-VL-incidence distribution may be due to lower exposure to infectious sandfly bites in young children, but also suggest that acquired immunity to the parasite increases with age. However, poor standardisation of serological tests makes it difficult to compare data from different studies and draw firm conclusions about drivers of variation in observed age patterns.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>30521526</pmid><doi>10.1371/journal.pntd.0006803</doi><orcidid>https://orcid.org/0000-0001-7727-7102</orcidid><orcidid>https://orcid.org/0000-0002-5740-9734</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1935-2735 |
ispartof | PLoS neglected tropical diseases, 2018-12, Vol.12 (12), p.e0006803-e0006803 |
issn | 1935-2735 1935-2727 1935-2735 |
language | eng |
recordid | cdi_plos_journals_2262859095 |
source | MEDLINE; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; PubMed Central Open Access; Public Library of Science (PLoS) |
subjects | Age Age composition Age Distribution Age groups Agglutination tests Asia, Western - epidemiology Asymptomatic infection Biology and Life Sciences Bites Catalysis Children Collating Correlation analysis Data Data analysis Data collection Demographic aspects Diagnostic systems Disease age factors Disease transmission Distribution Dynamic models Epidemiology Female Geographical distribution Geographical locations Health surveillance Humans Immunity Incidence Infections Infectious diseases Insect bites Leishmania donovani Leishmania donovani - immunology Leishmania donovani - isolation & purification Leishmaniasis, Visceral - diagnosis Leishmaniasis, Visceral - epidemiology Leishmaniasis, Visceral - parasitology Leishmaniasis, Visceral - transmission Leishmanin Life sciences Longitudinal Studies Male Medical research Medicine Medicine and Health Sciences Models, Statistical Parasites Parasitic diseases People and Places Prevalence Programmes Public health Research and Analysis Methods Reversion Seroepidemiologic Studies Serological tests Serology Skin Skin tests Statistical analysis Statistical tests Studies Transmission Trends Tropical diseases Vector-borne diseases Visceral leishmaniasis |
title | Age trends in asymptomatic and symptomatic Leishmania donovani infection in the Indian subcontinent: A review and analysis of data from diagnostic and epidemiological studies |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T19%3A38%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Age%20trends%20in%20asymptomatic%20and%20symptomatic%20Leishmania%20donovani%20infection%20in%20the%20Indian%20subcontinent:%20A%20review%20and%20analysis%20of%20data%20from%20diagnostic%20and%20epidemiological%20studies&rft.jtitle=PLoS%20neglected%20tropical%20diseases&rft.au=Chapman,%20Lloyd%20A%20C&rft.date=2018-12-01&rft.volume=12&rft.issue=12&rft.spage=e0006803&rft.epage=e0006803&rft.pages=e0006803-e0006803&rft.issn=1935-2735&rft.eissn=1935-2735&rft_id=info:doi/10.1371/journal.pntd.0006803&rft_dat=%3Cgale_plos_%3EA568167762%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2262859095&rft_id=info:pmid/30521526&rft_galeid=A568167762&rft_doaj_id=oai_doaj_org_article_9340fb31b3074c87bdb7c50c2fa53666&rfr_iscdi=true |